VVOS — Vivos Therapeutics Inc
NASDAQ · Healthcare · Medical Devices
$0.17
-$0.03 (-13.98%)
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ. It is led by R. Kirk Huntsman, based in 7921 Southpark Plaza, Littleton, CO, United States, 80120, with about 270 employees. Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
Latest reported VVOS revenue for 2025-09-30 was $6.8M. Net income was -$5.4M. Revenue was up 77.6% from 2025-06-30 to 2025-09-30. VVOS currently screens at market cap $7.1M.
Use this VVOS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VVOS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VVOS SEC filings page. Lician reads the product cache first so this HTML stays unique to Vivos Therapeutics Inc even when a live quote feed is slow.
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
VVOS Key Statistics
Market Cap
$7.10M
Volume
14.97M
Previous Close
$0.27
Day Range
$0.25 – $0.27
P/B Ratio
6.86
EPS
-$2.22
Revenue
$15.03M
Net Income
-$11.14M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+8.9%
Profit Margin
-74.1%
Employees
270
VVOS Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $15.03M | $13.80M | $16.02M | $16.89M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$11.14M | -$13.58M | -$23.84M | -$20.29M |
| EPS (Diluted) | -$2.22 | -$11.14 | -$25.90 | $0.00 |
Total Assets
$15.28M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$6.26M
Operating Cash Flow
-$12.69M
Free Cash Flow
$0.00
Vivos Therapeutics Inc Company Information
- Co-Founder, Chairman of the Board & CEO
- R. Kirk Huntsman
- Headquarters
- 7921 Southpark Plaza, Littleton, CO, United States, 80120
- Website
- www.vivos.com
- Phone
- 866 908 4867
- IPO / Founded
- 2020-12-11
- Sector
- Healthcare
- Industry
- Medical Devices